Cited by 9Dermatology and Skin DiseasesSkin Protection and AgingAdvancements in Transdermal Drug Delivery

Transcriptomic Analysis of Human Keratinocytes Treated with Galactomyces Ferment Filtrate, a Beneficial Cosmetic Ingredient

Open access
Nakajima, Akiko, Sakae, Nahoko, Yan, Xianghong, Hakozaki, Tomohiro, Zhao, Wenzhu, Laughlin, Timothy, Furue, Masutaka·2022·Journal of Clinical Medicine

Abstract

Galactomyces ferment filtrate (GFF, Pitera™) is a cosmetic ingredient known to have multiple skin care benefits, such as reducing redness and pore size via the topical application of its moisturizer form. Although GFF is known to act partly as an antioxidative agonist for the aryl hydrocarbon receptor (AHR), its significance in keratinocyte biology is not fully understood. In this study, we conducted a transcriptomic analysis of GFF-treated human keratinocytes. Three different lots of GFF consistently modulated 99 (22 upregulated and 77 downregulated) genes, including upregulating cytochrome P450 1A1 (CYP1A1), a specific downstream gene for AHR activation. GFF also enhanced the expression of epidermal differentiation/barrier-related genes, such as small proline-rich proteins 1A and 1B (SPRR1A and SPRR1B), as well as wound healing-related genes such as serpin B2 (SERPINB2). Genes encoding components of tight junctions claudin-1 (CLDN1) and claudin-4 (CLDN4) were also target genes upregulated in the GFF-treated keratinocytes. In contrast, the three lots of GFF consistently downregulated the expression of inflammation-related genes such as chemokine (C-X-C motif) ligand 14 (CXCL14) and interleukin-6 receptor (IL6R). These results highlight the beneficial properties of GFF in maintaining keratinocyte homeostasis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm11164645

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 35

  1. [1]Tsukahara K. Sugata K. Osanai O. Ohuchi A. Miyauchi Y. Takizawa M. Hotta M. Kitahara T. Comparison of age-related changes in facial wrinkles and sagging in the skin of Japanese, Chinese and Thai women J. Dermatol. Sci. 2007 47 19 28 10.1016/j.jdermsci.2007.03.007 17499481 · DOI
  2. [2]Miyamoto K. Dissanayake B. Omotezako T. Takemura M. Tsuji G. Furue M. Daily fluctuation of facial pore area, roughness and redness among young Japanese women; Beneficial effects of Galactomyces ferment filtrate containing antioxidative skin care formula J. Clin. Med. 2021 10 2502 10.3390/jcm10112502 34198790 PMC8200969 · DOI · Paper page
  3. [3]Miyamoto K. Inoue Y. Hsueh K. Liang Z. Yan X. Yoshii T. Furue M. Characterization of comprehensive appearances of skin ageing: An 11-year longitudinal study on facial skin ageing in Japanese females at Akita J. Dermatol. Sci. 2011 64 229 236 10.1016/j.jdermsci.2011.09.009 22015051 · DOI · Paper page
  4. [4]Miyamoto K. Munakata Y. Yan X. Tsuji G. Furue M. Enhanced fluctuations in facial pore size, redness, and TEWL caused by mask usage are normalized by the application of a moisturizer J. Clin. Med. 2022 11 2121 10.3390/jcm11082121 35456214 PMC9030563 · DOI · Paper page
  5. [6]Kypriotou M. Huber M. Hohl D. The human epidermal differentiation complex: Cornified envelope precursors, S100 proteins and the ‘fused genes’ family Exp. Dermatol. 2012 21 643 649 10.1111/j.1600-0625.2012.01472.x 22507538 · DOI
  6. [7]Tsai H.H. Chen Y.C. Lee W.R. Hu C.H. Hakozaki T. Yoshii T. Shen S.C. Inhibition of inflammatory nitric oxide production and epidermis damages by Saccharomycopsis ferment filtrate J. Dermatol. Sci. 2006 42 249 257 10.1016/j.jdermsci.2006.01.009 16533596 · DOI
  7. [8]Furue M. Uchi H. Mitoma C. Hashimoto-Hachiya A. Chiba T. Ito T. Nakahara T. Tsuji G. Antioxidants for healthy skin: The emerging role of aryl hydrocarbon receptors and nuclear factor-erythroid 2-related factor-2 Nutrients 2017 9 223 10.3390/nu9030223 PMC5372886 28273792 · DOI · Paper page
  8. [9]Hashimoto-Hachiya A. Tsuji G. Furue M. Antioxidants cinnamaldehyde and Galactomyces fermentation filtrate downregulate senescence marker CDKN2A/p16INK4A via NRF2 activation in keratinocytes J. Dermatol. Sci. 2019 96 53 56 10.1016/j.jdermsci.2019.09.002 31606066 · DOI · Paper page
  9. [10]Cooper J.K.W. Koshoffer A. Kadekaro A.L. Hakozaki T. Boissy R. Galactomyces ferment filtrate suppresses reactive oxygen species generation and promotes cellular redox balance in human melanocytes via Nrf2-ARE pathway J. Clin. Cosmet. Dermatol. 2019 3 10.16966/2576-2826.138 · DOI
  10. [12]Furuse M. Hata M. Furuse K. Yoshida Y. Haratake A. Sugitani Y. Noda T. Kubo A. Tsukita S. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: A lesson from claudin-1-deficient mice J. Cell Biol. 2002 156 1099 1111 10.1083/jcb.200110122 11889141 PMC2173463 · DOI · Paper page
  11. [13]Aono S. Hirai Y. Phosphorylation of claudin-4 is required for tight junction formation in a human keratinocyte cell line Exp. Cell Res. 2008 314 3326 3339 10.1016/j.yexcr.2008.08.012 18786529 · DOI
  12. [14]Olsen E. Rasmussen H.H. Celis J.E. Identification of proteins that are abnormally regulated in differentiated cultured human keratinocytes Electrophoresis 1995 16 2241 2248 10.1002/elps.11501601356 8824783 · DOI
  13. [15]Schäfer M. Farwanah H. Willrodt A.H. Huebner A.J. Sandhoff K. Roop D. Hohl D. Bloch W. Werner S. Nrf2 links epidermal barrier function with antioxidant defense EMBO Mol. Med. 2012 4 364 379 10.1002/emmm.201200219 22383093 PMC3403295 · DOI
  14. [16]Lu J. Chatterjee M. Schmid H. Beck S. Gawaz M. CXCL14 as an emerging immune and inflammatory modulator J. Inflamm. 2016 13 1 10.1186/s12950-015-0109-9 PMC4700668 26733763 · DOI
  15. [17]Hasegawa T. Feng Z. Yan Z. Ngo K.H. Hosoi J. Demehri S. Reduction in human epidermal Langerhans cells with age is associated with decline in CXCL14-mediated recruitment of CD14+ monocytes J. Cosmet. Dermatol. Sci. Appl. 2020 140 1327 1334 10.1016/j.jid.2019.11.017 PMC8142052 31881212 · DOI
  16. [18]Wood L.C. Stalder A.K. Liou A. Campbell I.L. Grunfeld C. Elias P.M. Feingold K.R. Barrier disruption increases gene expression of cytokines and the 55 kD TNF receptor in murine skin Exp. Dermatol. 1997 6 98 104 10.1111/j.1600-0625.1997.tb00154.x 9209892 · DOI
  17. [19]Terunuma A. Aiba S. Tagami H. Cytokine mRNA profiles in cultured human skin component cells exposed to various chemicals: A simulation model of epicutaneous stimuli induced by skin barrier perturbation in comparison with that due to exposure to haptens or irritant J. Dermatol. Sci. 2001 26 85 93 10.1016/S0923-1811(00)00165-1 11378323 · DOI
  18. [20]Engelhart K. El Hindi T. Biesalski H.K. Pfitzner I. In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models Arch. Dermatol. Res. 2005 297 1 9 10.1007/s00403-005-0575-7 15952007 · DOI
  19. [21]Shay J.W. Wright W.E. Use of telomerase to create bioengineered tissues Ann. NY Acad. Sci. 2005 1057 479 491 10.1196/annals.1356.037 16399914 · DOI
  20. [22]Fang B. Card P.D. Chen J. Li L. Laughlin T. Jarrold B. Zhao W. Benham A.M. Määttä A.T. Hawkins T.J. A potential role of keratinocyte-derived bilirubin in human skin yellowness and its amelioration by sucrose laurate/dilaurate Int. J. Mol. Sci. 2022 23 5884 10.3390/ijms23115884 35682565 PMC9180758 · DOI
  21. [23]Ritchie M.E. Phipson B. Wu D. Hu Y. Law C.W. Shi W. Smyth G.K. limma powers differential expression analyses for RNA-sequencing and microarray studies Nucleic Acids Res. 2015 43 e47 10.1093/nar/gkv007 25605792 PMC4402510 · DOI · Paper page
  22. [25]Purba T.S. Ng’andu K. Brunken L. Smart E. Mitchell E. Hassan N. O’Brien A. Mellor C. Jackson J. Shahmalak A. CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane-induced alopecia EMBO Mol. Med. 2019 11 e11031 10.15252/emmm.201911031 31512803 PMC6783643 · DOI
  23. [26]Bygum A. Fagerberg C.R. Clemmensen O.J. Fiebig B. Hafner C. Systemic epidermal nevus with involvement of the oral mucosa due to FGFR3 mutation BMC Med. Genet. 2011 12 79 10.1186/1471-2350-12-79 21639936 PMC3119182 · DOI
  24. [27]Duperret E.K. Oh S.J. McNeal A. Prouty S.M. Ridky T.W. Activating FGFR3 mutations cause mild hyperplasia in human skin, but are insufficient to drive benign or malignant skin tumors Cell Cycle 2014 13 1551 1559 10.4161/cc.28492 24626198 PMC4050160 · DOI
  25. [28]Kennedy L.H. Sutter C.H. Leon Carrion S. Tran Q.T. Bodreddigari S. Kensicki E. Mohney R.P. Sutter T.R. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated production of reactive oxygen species is an essential step in the mechanism of action to accelerate human keratinocyte differentiation Toxicol. Sci. 2013 132 235 249 10.1093/toxsci/kfs325 23152189 PMC3576006 · DOI · Paper page
  26. [29]Hashimoto-Hachiya A. Tsuji G. Murai M. Yan X. Furue M. Upregulation of FLG, LOR, and IVL Expression by Rhodiola crenulata Root Extract via Aryl Hydrocarbon Receptor: Differential Involvement of OVOL1 Int. J. Mol. Sci. 2018 19 1654 10.3390/ijms19061654 PMC6032276 29866992 · DOI
  27. [30]Tsuji G. Hashimoto-Hachiya A. Kiyomatsu-Oda M. Takemura M. Ohno F. Ito T. Morino-Koga S. Mitoma C. Nakahara T. Uchi H. Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis Cell Death Dis. 2017 8 e2931 10.1038/cddis.2017.322 28703805 PMC5550867 · DOI · Paper page
  28. [31]Rusni S. Sassa M. Takagi T. Kinoshita M. Takehana Y. Inoue K. Establishment of cytochrome P450 1a gene-knockout Javanese medaka, Oryzias javanicus, which distinguishes toxicity modes of the polycyclic aromatic hydrocarbons, pyrene and phenanthrene Mar. Pollut. Bull. 2022 178 113578 10.1016/j.marpolbul.2022.113578 35344733 · DOI
  29. [32]Christmann C. Zenker S. Martens L. Hübner J. Loser K. Vogl T. Roth J. Interleukin 17 promotes expression of alarmins S100A8 and S100A9 during the inflammatory response of keratinocytes Front. Immunol. 2021 11 599947 10.3389/fimmu.2020.599947 33643287 PMC7906991 · DOI
  30. [33]Skeate J.G. Porras T.B. Woodham A.W. Jang J.K. Taylor J.R. Brand H.E. Kelly T.J. Jung J.U. Da Silva D.M. Yuan W. Herpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infection J. Gen. Virol. 2016 97 422 434 10.1099/jgv.0.000341 26555393 PMC4804641 · DOI
  31. [34]Lessard J.C. Piña-Paz S. Rotty J.D. Hickerson R.P. Kaspar R.L. Balmain A. Coulombe P.A. Keratin 16 regulates innate immunity in response to epidermal barrier breach Proc. Natl. Acad. Sci. USA 2013 110 19537 19542 10.1073/pnas.1309576110 24218583 PMC3845144 · DOI
  32. [35]Zhang X. Yin M. Zhang L.J. Keratin 6, 16 and 17-critical barrier alarmin molecules in skin wounds and psoriasis Cells 2019 8 807 10.3390/cells8080807 PMC6721482 31374826 · DOI
  33. [36]Huang S.W. Wang S.T. Chang S.H. Chuang K.C. Wang H.Y. Kao J.K. Liang S.M. Wu C.Y. Kao S.H. Chen Y.J. Imiquimod exerts antitumor effects by inducing immunogenic cell death and is enhanced by the glycolytic inhibitor 2-deoxyglucose J. Investig. Dermatol. 2020 140 1771 1783 10.1016/j.jid.2019.12.039 32035924 · DOI
  34. [37]Feng M. Marjon K.D. Zhu F. Weissman-Tsukamoto R. Levett A. Sullivan K. Kao K.S. Markovic M. Bump P.A. Jackson H.M. Programmed cell removal by calreticulin in tissue homeostasis and cancer Nat. Commun. 2018 9 3194 10.1038/s41467-018-05211-7 30097573 PMC6086865 · DOI
  35. [38]Krysko D.V. Ravichandran K.S. Vandenabeele P. Macrophages regulate the clearance of living cells by calreticulin Nat. Commun. 2018 9 4644 10.1038/s41467-018-06807-9 30405101 PMC6220184 · DOI

Cited by

Sorted by citations

Authors
Nakajima, A., Sakae, N., Yan, X., Hakozaki, T., Zhao, W., Laughlin, T., & Furue, M.
Affiliations
  • Procter & Gamble Japan K.K. (Japan) (JP)
  • Procter & Gamble (United States) (US)
  • Kyushu University (JP)
Corresponding author
Nakajima, Akiko
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2022-08-09
Volume
11
Issue
16
Pages
4645
ISSN
2077-0383 (ISSN-L)
OpenAlex
W4293512621
Cited by
9
References
2
Citations by year
2026: 2 · 2024: 4 · 2023: 2 · 2022: 1
FWCI
1.71
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Dermatology › Skin Protection and Aging
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords
keratinocytes, aryl hydrocarbon receptor, CYP1A1, epidermal differentiation, skin barrier, tight junctions, claudin-1, claudin-4, wound healing, inflammation, CXCL14, IL-6 receptor, gene expression profiling, cosmetic ingredients

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review